Canada’s struggle with substance use is more than a health issue—it’s a matter of language, policy, and public trust, said Dr. Kwame McKenzie in the latest episode of the Global Health Matters podcast with Dr. Garry Aslanyan. McKenzie, CEO of the Wellesley Institute and Director of Health Equity at Canada’s Centre for Addiction and Mental […] Continue reading ->
Dr Joanne Liu, a veteran humanitarian and former international president of Médecins Sans Frontières (MSF), has seen the front lines of global health crises—from Ebola in West Africa to bombed-out hospitals in Afghanistan. But her message today is clear: “An imperfect solution is better than no solution.” Speaking on the Global Health Matters podcast, Liu […] Continue reading ->
The world faces a global health funding crisis, but John-Arne Røttingen believes the solution goes beyond money. It lies in stronger partnerships between governments, researchers, and citizens. “Science is not enough to change the world,” said Røttingen, the newly appointed CEO of Wellcome, one of the world’s largest global health foundations. “It must be allied […] Continue reading ->
Artificial intelligence can transform global health—but only if developed and deployed with equity in mind. That was the message from two global health experts featured on the latest Global Health Matters podcast episode, “AI for Equity: Bridging Global Health Gaps.” “In the future, a physician working in a remote area will have the best cardiologist […] Continue reading ->
Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading ->
A human embryo’s DNA is “edited” to take out a disease. Surgeons practice complicated procedures on models created by 3-D printers. A pre-programmed drone collects blood samples from residents of a rural village and travels back to the capital. These awe-inspiring scenarios have all recently unfolded in what is undoubtedly a golden era of innovation in healthcare. Continue reading ->
Surely, the topic of human mobility has been the stumbling block in the common agenda of European countries for the last few years. In fact, the very existence of the European Union as we have known it so far is at stake, on this political issue. A certain degree of prudence would seem understandable, then, a few months ahead of the May EU elections. Surely, the intergovernmental nature of the UN agencies force them to interact with Member States, that is why exacerbating the political arena is a risky operation that may not pay off at all, in the long run. Moreover, for WHO Europe, the report on the health of refugees and migrant people in the 53 countries of the region is the first one of its kind, which may explain the hesitance of the beginner. But it is difficult to deny a bitter aftertaste, especially after the press conference. Continue reading ->
Funding for neglected disease research and development reached its highest level in a decade, with US $3.56 billion in investments in 2017. Continue reading ->
A new report released today by PATH, the international global health NGO, shows that some 23,000 lives a year could be saved through more harmonised regulatory processes for health products in southern and eastern Africa – and this just for two essential medications that were subjected to the review. Continue reading ->
Compulsory public finance remains a key mechanism for achieving universal health coverage (UHC), according to Professor Robert Yates of the Centre on Global Health Security at the London-based Chatham House, Royal Institute of International Affairs. Continue reading ->